NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill may keep ovarian cancer at bay for longer in women with BRCA mutations
Disease control OngoingThis study tests whether taking olaparib daily after initial chemotherapy can delay the return of advanced ovarian cancer in women with BRCA gene mutations. About 450 women whose cancer responded to platinum-based chemo will receive either olaparib or a placebo. The goal is to se…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New hope for brain cancer? drug combo trial targets glioblastoma
Disease control OngoingThis early-phase trial tests a new drug called selinexor alongside standard chemotherapy and radiation for people with newly diagnosed glioblastoma, a fast-growing brain cancer. The main goal is to find the highest safe dose of selinexor that can be given with the standard treatm…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC